Sites |
Bispecific Antibody Therapeutics Market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis
Read Detailed Analysis: https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html
|
Bispecific Antibody Therapeutics Market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis
Read Detailed Analysis: https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html
|
Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis
Request for Customization: https://www.rootsanalysis.com/reports/281/request-sample.html
|
More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are over 25 technology platforms available for use in therapy development efforts
|
Roots Analysis offers market research reports highlighting insightful opinions within the pharma, biotech and medical devices industry. With over 500 clients spread across the small pharma, large pharma, VC firms and academic institutes, our intellectual capital encompasses very niche / emerging market segments.
|